Journal of Dermatological Treatment

Article	Citations
Skin type classifications: does the perfect assessment exist?	84
Response to fumaric acid esters for plaque type psoriasis in real-world practice is largely independent of patient characteristics at baseline – a multivariable regression analysis from the German Pso	77
Long-term real-world evidence of SB5 (adalimumab biosimilar) treatment in patients with moderate-to-severe psoriasis from the British Association of Dermatologists Biologic and Immunomodulators Regist	62
Ixekizumab is effective in the long-term management in moderate-to-severe plaque psoriasis: results from an Italian retrospective cohort study (the LOTIXE study)	55
Practical considerations relevant to treatment with the gene therapy beremagene geperpavec-svdt for dystrophic epidermolysis bullosa	50
Lessons from a decentralized trial in atopic dermatitis: promises and perils	42
A CollaboraTive Initiative of worldwide Vitiligo Experts and patients to define vitiligo activity (ACTIVE): study protocol	39
The hf-PGA is a valid and reliable measure of hand/foot psoriasis severity in adults: results from a phase 2b clinical trial	38
Pretreatment Demodex infestation predicts dupilumab-associated blepharoconjunctivitis in atopic dermatitis	37
Network meta-analyses comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis at 24–28 and 48–52 weeks	33
Ruxolitinib cream monotherapy for facial and/or neck atopic dermatitis: results from a decentralized, randomized phase 2 clinical trial	30
Topical delgocitinib for the treatment of chronic hand eczema	29
Ixekizumab-induced interstitial lung disease: a case report confirmed by transbronchial lung cryobiopsy	28
On-label persistence in psoriasis after switching to guselkumab, tumor necrosis factor inhibitors, interleukin-17 inhibitors, or apremilast from other advanced therapies	28
A systematic review of recent randomized controlled trials for palmoplantar pustulosis	28
Tildrakizumab 200 mg: a step forward in psoriasis treatment with added metabolic benefits	28
Correction	27
Insights into treatment of patients with mycosis fungoides or Sézary syndrome using mogamulizumab	27
Artificial intelligence-based prescription of personalized scalp cosmetics improved the scalp condition: efficacy results from 100 participants	26
Patients’ preferences for systemic treatment of atopic dermatitis: safety and efficacy count the most	25
Patient perspective on symptoms of Notalgia paresthetica: subpopulation results from the Neuropathic Itch Patient Survey (NIRVE)	24
Effectiveness and safety of interferon α-2a combined with phototherapy for patients with early-stage mycosis fungoides - a single-arm prospective study in 13 patients	24
Impairment in work and activities of daily life in patients with psoriasis: results of the prospective BioCAPTURE registry	24
Probiotics for the prevention of atopic dermatitis in infants from different geographic regions: a systematic review and Meta-analysis	24
Identification of clinical predictors for dupilumab dose spacing in adults with atopic dermatitis: a real-world study	23

Drug survival analysis of dupilumab and cyclosporin in patients with atopic dermatitis: a multicenter study	23
A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years	22
Driving taxis	22
Comparative effectiveness of tildrakizumab 200 mg versus tildrakizumab 100 mg in psoriatic patients with high disease burden or above 90 kg of body weight: a 16-week multicenter retrospective study –	22
Clinical observation of 10 cases of stable non-segmental vitiligo in adults treated with upadacitinib	21
Rapid improvement of kimura disease with dupilumab in a patient with suboptimal response to mepolizumab: a case report	21
The efficacy and safety of low-dose rituximab in the treatment of pemphigus vulgaris: a cohort study	21
A pediatric case of dupilumab-induced pustular psoriasis	21
The expression of CD200 and CD23 on B lymphocytes in the pollen season and outside the pollen season in atopic dermatitis patients with and without dupilumab therapy	21
Finally, successful interventions to ameliorate cutaneous infestations	21
Real-life effectiveness and safety of dupilumab in adolescents with atopic dermatitis: a 52-week single-center retrospective study	20
The effect of tildrakizumab on adipokines production in patients affected by psoriasis and obesity: preliminary results from a single center real-life study	20
Long-Term efficacy and safety analysis of secukinumab in the treatment of pediatric generalized pustular psoriasis: a real-world study	20
Duration of current alopecia areata episode predicts the effectiveness of baricitinib in Japanese patients with alopecia areata: a single-center retrospective study	20
Off-label use of upadacitinib in dermatology: a review	19
Efficacy and safety of sofpironium in treatment of primary hyperhidrosis: a systematic review	19
Comparative efficacy of omalizumab, dupilumab, and remibrutinib in chronic spontaneous urticaria: a network meta-analysis of randomized control trials	19
Preoperative and postoperative evaluation of survivin in peripheral blood of patients with non-melanoma skin cancers. A pilot study	18
A therapeutic challenge: managing severe atopic dermatitis with concurrent alpha-1-antitrypsin deficiency	18
The changes of leukocytes and T lymphocytes in atopic dermatitis patients with and without dupilumab therapy and in control group in pollen season compared to out of pollen season	18
Treatment patterns and healthcare costs among patients with psoriasis initiating apremilast or biologics: a retrospective claims database cohort analysis	18
Nemolizumab for chronic pruritus beyond atopic dermatitis and prurigo nodularis: a systematic review and synthesis of emerging evidence	17
Racial and ethnic diversity of US participants in clinical trials for acne, atopic dermatitis, and psoriasis: a comprehensive review	17
Efficacy of skin flap transfer combined with negative pressure wound therapy in the management of complex pressure ulcers	17
Correction	16
‘Oral isotretinoin plus desloratadine for acne vulgaris: an updated global meta-analysis of efficacy, safety, and patient-centered outcomes’	16
Persistence of interleukin-17 and interleukin-23 inhibitors in patients with plaque psoriasis: a real-world study in Taiwan	16
Psychosocial interventions for psoriasis: a Bayesian network meta-analysis	16
Effectiveness of risankizumab in plaque psoriasis with involvement of difficult-to-treat areas: a real-world experience from two referral centers	16
Intramuscular ertapenem for the treatment of severe cases hidradenitis suppurativa	15
Predictive factors for early super response to bimekizumab in 341 patients with psoriasis—a 24-week short-term multicenter real-life experience	15
From clinical trial to real world evidence: a learning healthcare environment	15
Periocular molluscum contagiosum in an atopic dermatitis patient treated with upadacitinib	15
Apremilast for the treatment of pustular psoriasis induced by neoadjuvant ifosfamide + etoposide chemotherapy for Ewing Sarcoma: a case report	15
Systematic review, methodological appraisal, and recommendation mapping of clinical practice guidelines for managing patients with Stevens-Johnson syndrome and toxic epidermal necrolysis	15
Exploring the potential of nanocarriers in antipsoriatic therapeutics	15
Correction	14
Utilizing artificial intelligence technology with emotional intelligence in clinical office visits	14
Photodynamic therapy combined with surgery versus Mohs micrographic surgery for the treatment of difficult-to-treat basal cell carcinoma: a retrospective clinical study	14
Uses of eye drops in dermatology, literature review	14
Dupilumab in papuloerythroderma of Ofuji: therapeutic efficacy and paradoxical flares in a case-based review	14
Years of dermatology experience and geographic region are associated with outlier performance of excision or destruction for nonmelanoma skin cancer	14
Pre-operative ultrasound localization of misdiagnosed foreign object as verruca vulgaris: a case report	14
Vitiligo outpatient management in the United States: findings from the 2012–2019 National Ambulatory Medical care Survey (NAMCS)	13
Real-world outcomes following switching from anti-TNF reference products to biosimilars for the treatment of psoriasis	13
Managing dry skin in patients with comorbidities or with advanced age: unmet needs and roles for products containing potential emollient-plus ingredients	13
Treatment persistence of interleukin-17 inhibitor class drugs among patients with psoriasis in Japan: a retrospective database study	13
Boxed warnings for dermatologic JAK inhibitors: are they standardized worldwide?	13
Successful treatment of SAPHO syndrome with oral abrocitinib: a case report	13
Effectiveness of tildrakizumab 200 mg: an Italian multicenter study	13

Comparison of safety profile in patients with atopic dermatitis treated with dupilumab or conventional systemic treatment: real world data from the US network	13
Depression and depressive symptoms among people living with vitiligo: findings from the cross-sectional, population-based global VALIANT survey	13
A practical algorithm for the treatment of mild-to-moderate atopic dermatitis (AD) in pediatric patients in Europe: expert recommendations	13
Letter to the editor submitted in response to ‘Are potential remittive properties of OX-40 inhibitors something to be excited about?’	12
Comparative efficacy of targeted systemic therapies for pruritus in moderate-to-severe atopic dermatitis without topical treatment: a network meta-analysis	12
Switching to risankizumab from ustekinumab or adalimumab in plaque psoriasis patients improves PASI and DLQI outcomes for sub-optimal responders	12
Teledermatological services at a Swiss university hospital - evaluation of patient benefits and economic impact	12
Real-world biologic treatment patterns and healthcare resource utilization in psoriasis patients using an insurance claims database in Japan	12
The development and initial evaluation of conversation cards for optimizing consultations for patients with atopic dermatitis	12
Schnitzler syndrome refractory to anakinra: successful treatment with canakinumab	12
Non-medical switching in dermatology: cost-conscious policy or an affront to patient safety?	12
Polynucleotide-based treatments for various facial scars including combat injuries	12
Social determinants of health, quality of life, and productivity outcomes among adults with vitiligo in Brazil, China, India, and South Africa	11
Injection site reactions after dupilumab or tralokinumab for atopic dermatitis	11
Clinical efficacy of platelet-rich fibrin in chronic wound healing: a retrospective study	11
Injectable platelet-rich fibrin as a valid therapeutic option for inactive linear morphea (en coup de saber): report of cases	11
Invasive Aspergillus infection of middle ear in a patient treated with secukinumab, methotrexate, and corticosteroids for psoriasis and psoriatic arthritis	11
A new method to treat onychopapilloma with pulsed dye laser irradiation: a 13-case series report	11
Improvements in acne and skin oiliness with tazarotene 0.045% lotion in patients with oily skin	11
Efficacy and safety of topical 3% minoxidil for facial hair enhancement in transmen: a randomized, double-blind, placebo-controlled trial	11
Efficacy of oral isotretinoin monotherapy compared to combination isotretinoin and topical clascoterone for severe acne vulgaris: a multi-center retrospective study	11
Flumethasone-salicylic acid cream effectively flattened verrucous epidermal nevus: a case report	10
Comparison of various excimer laser (EL) combination therapies for vitiligo: a systematic review and network meta-analysis	10
Comparison of long-term efficacy and safety of different therapeutic approaches for vulvar Lichen sclerosus: a systematic review and meta-analysis	10
Management of comorbid Crohn’s disease and alopecia universalis with upadacitinib and oral minoxidil	10
New insights into delusional infestation	10
Characterization and therapeutic strategies for refractory vulvar lichen sclerosus: an 8-year single-center retrospective study and current evidence synthesis	10
Assessment of patient-reported outcomes at 24 weeks of treatment with tralokinumab for atopic dermatitis: a multicentric real-life experience	10
Multiple COVID reinfections in a vaccinated psoriatic patient receiving adalimumab	10
Doxycycline monotherapy for pyoderma vegetans: a case report	10
Treatment of eosinophilic annular erythema with upadacitinib	10
Personalized prediction of psoriasis relapse post-biologic discontinuation: a machine learning-driven population cohort study	10
Initiation of apremilast treatment decreases prescribed topical therapy amount in patients with psoriasis: a health insurance claims study in Japan	10
Botanical extract combined with minoxidil improve hidrotic ectodermal dysplasia caused by p.G11R mutations: a case report	10
Improving the quality of life of patients with inflammatory skin diseases: a multicenter evaluation of a ceramide-containing regimen in patients with atopic dermatitis, psoriasis and xerosis	10
Five-year safety of tildrakizumab in patients with moderate-to-severe psoriasis from two phase 3 trials (reSURFACE 1 and reSURFACE 2): number needed to harm for occurrence of adverse events of special	10
Biodegradable polymers and platelet-rich plasma causing visual impairment: a literature review	10
Comparative efficacy of targeted systemic therapies for moderate-to-severe atopic dermatitis: a network meta-analysis of phase 3–4 randomized trials	10
Complementary and alternative treatment methods practiced by parents in pediatric cases diagnosed with atopic dermatitis	9
Efficacy and safety of tranilast combined with minocycline in the treatment of moderate-to-severe rosacea: a prospective, randomized controlled study	9
A case of generalized eosinophilic pustular folliculitis: treatment with JAK inhibitor	9
Methodologic considerations in evaluating early clinical outcomes of GT20029 for androgenetic alopecia	9
The efficacy of combined phototherapy with topical therapy in vitiligo: a network meta-analysis	9
Effectiveness and safety of Baricitinib in alopecia areata: a prospective cohort study	9
Severe papulopustular rosacea successfully treated with a combination of oral azithromycin and isotretinoin	9
Reduction of impairment of sexual activity in patients with genital psoriasis treated with risankizumab: interim results of a real-world study	9
Rosacea-like skin reaction under treatment with dupilumab for atopic dermatitis	9
Treatment of discoid lupus erythematosus with crisaborole	9
Apremilast in the treatment of pityriasis lichenoides et varioliformis acuta: a case report	9
Efficacy and safety of 308-nm Excimer lamp combined with Tacrolimus 0.1% ointment vs Tacrolimus 0.1% ointment as monotherapy in treating children with limited vitiligo: a randomized controlled trial	9
Evaluation of innate lymphoid cells and their subsets in atopic dermatitis patients with and without dupilumab therapy	9
Successful treatment of generalized pustular psoriasis during pregnancy with secukinumab in a patient hypersensitive to spesolimab: a case report	9
Comparison of the efficacy of tacrolimus 0.1% ointment vs calcipotriol/betamethasone in combination with NBUVB in treatment of vitiligo	9
Longer-term safety and efficacy of baricitinib for atopic dermatitis in pediatric patients 2 to <18 years old: a randomized clinical trial of extended treatment to 3.6 years	9
Clinical observations on super relaxation suture in the resection of benign skin tumor in children	8
Comparative efficacy of matrix phenolization and nail bed reconstruction for pincer nail deformity: a retrospective study	8
Real-world use, perception, satisfaction, and adherence of calcipotriol and betamethasone dipropionate PAD-cream in patients with plaque psoriasis in Spain and Germany: results from a cross-sectional,	8
A real-world study to assess the disease control of moderate to severe atopic dermatitis in patients receiving dupilumab therapy, with atopic dermatitis control tool in Gulf countries	8
Efficacy and safety of brivudine for the treatment of herpes zoster: a systematic review and meta-analysis	8
Expanding the therapeutic horizons of spesolimab: a review of off-label applications for inflammatory skin diseases	8
Efficacy and safety of stromal vascular fraction on scar revision surgery: a prospective study	8
Prurigo nodularis enters the biologic era: what has changed and what vixarelimab still must prove	8
Angiolymphoid hyperplasia with eosinophilia responded well to dupilumab in two cases	8
Dupilumab for Hailey-Hailey disease	8
Whether the transient hair shedding phase exist after minoxidil treatment and does it predict treatment efficacy? A retrospective study in androgenetic alopecia patients	8
Treatment satisfaction of adult patients with moderate-to-severe atopic dermatitis treated with baricitinib in France, Germany, and the United Kingdom: results from a cross-sectional international pat	8
Experiences and coping behaviors of patients with psoriasis: a qualitative study	8
Assessing secondary adherence to topical treatments: scoping review revealing lack of standardized approach in clinical research	8
Corticosteroid-induced skin damage improved with pimecrolimus cream 1% treatment: a 1-year study in adults with mild to moderate atopic dermatitis	8
Soluble Fas Ligand, an overlooked target of therapy in dermatological and non-dermatological conditions	8
A case of junctional epidermolysis bullosa intermediate with collagen XVII deficiency treated with dupilumab	8
Successful treatment of cutaneous polyarteritis nodosa with baricitinib	8
Comparing Mohs micrographic surgery and wide local excision in the management of head and neck dermatofibrosarcoma protuberans: a scoping review	8
Silicone-induced granulomas successfully treated with adalimumab	8
Baseline hair loss severity as a potential confounder in studies on minoxidil and low-level laser therapy	8
Patient preferences for treatment attributes in moderate-to-severe atopic dermatitis: a discrete choice experiment	8
Use of upadacitinib in the treatment of moderate to severe atopic dermatitis: patient profiling, dose selection, and therapy modulation, what does real-life teach us?	8
RETRACTED ARTICLE: Secukinumab-induced paradoxical skin lesions, but successful treatment with tofacitinib in SAPHO syndrome: a case report	8
Letter to the editor submitted in response to “Minoxidil: a comprehensive review”	7
Observational study on postoperative JAK inhibitor and corticosteroid therapy following non-cultured epidermal cell suspension transplantation in stable vitiligo patients	7

A hyaluronic acid-based micro-filler improves superficial wrinkles and skin quality: a randomized prospective controlled multicenter study	7
Preliminary analysis of the efficacy of Mohs micrographic surgery combined with photodynamic therapy in a case of noninvasive extramammary Paget’s disease	7
Rapid and sustained improvements in itch and quality of life with upadacitinib plus topical corticosteroids in adults and adolescents with atopic dermatitis: 52-week outcomes from the phase 3 AD Up st	7
The effects of topical antimicrobial-corticosteroid combination therapy in comparison to topical steroids alone on the skin microbiome of patients with atopic dermatitis	7
Effectiveness and patient satisfaction of a Dutch patient decision aid for psoriasis – a pilot study	7
Provider-level prescription patterns among dermatologists utilizing injectable biologics in psoriasis treatment	7
Estimated cost savings and formulary coverage barriers in biosimilar adoption	7
Efficacy and safety of oral methotrexate versus oral mini pulse betamethasone therapy in the treatment of lichen planus: a comparative study	7
Emerging DNA & RNA editing strategies for the treatment of epidermolysis bullosa	7
Efficacy and safety of a novel 785 nm picosecond neodymium-doped yttrium aluminum garnet laser for the treatment of facial benign pigmented lesions in Asian skin: a pilot study	7
A case of topical imiquimod induced fatigue	7
Effects and safety of fire needle adjuvant chemical peels therapy in acne vulgaris: a systematic review and meta-analysis	7
UCOMB-real life data: treatment strategies for chronic urticaria patients with comorbidities	7
Vitiligo exacerbation during upadacitinib treatment for atopic dermatitis and improvement following a switch to abrocitinib: a case report	7
Two cases of lupus miliaris disseminatus faciei successfully treated with oral tofacitinib	7
Amorolfine hydrochloride cream and 2% crisaborole ointment: a study on their therapeutic benefits for keratotic tinea pedis	7
Impact of secukinumab on patient-reported outcomes in biologic-naive patients with psoriasis in a US real-world setting	7
Comparison of the onset, depth, and duration of cutaneous anesthesia between topical 10% lidocaine and EMLA creams: a randomized, intraindividual, comparative trial	7
Anatomical-based diagnosis and filler injection techniques: marionette line (static labiomandibular fold)	7
Five-year real-world drug survival of dupilumab in severe atopic dermatitis and associate predictors	7
A center-based, ambulatory care concept for hidradenitis suppurativa improves patient outcomes and is also cost-effective	7
Quality of life and patient-reported side effects of low-dose oral minoxidil in treating female pattern hair loss	7
Janus kinase 1 inhibitor abrocitinib for isolated nail lichen planus: a case report and literature review	7
Application of a subcutaneous tissue pedicle flap combined with a labial mucosa flap for reconstruction of full-thickness lower lip defects: a prospective observational study	7
Laboratory monitoring in patients with moderate to severe plaque psoriasis	7
Anti-IL-17A blockade did not significantly reduce inflammatory lesions in a placebo-controlled pilot study in adult patients with moderate to severe acne	7
Certolizumab treatment of localized pyoderma gangrenosum in a pregnant patient	7
CHILD syndrome combined linear porokeratosis in a patient with a good response to the topical lovastatin/cholesterol ointment	7
Maintained improvement in physician- and patient-reported outcomes with baricitinib in adults with moderate-to-severe atopic dermatitis who were treated for up to 104 weeks in a randomized trial	7
Evaluation of β2-microglobulin in the condition and prognosis of psoriasis patients	7
Treatment satisfaction of patients with psoriasis with topical therapy in a real-world setting: unmet need for higher effectiveness	7
Patient preferences for atopic dermatitis treatments: a discrete choice experiment	7
Abrocitinib monotherapy in Investigator’s Global Assessment nonresponders: improvement in signs and symptoms of atopic dermatitis and quality of life	7
The impact of hormones in autoimmune cutaneous diseases	7